secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2024-09-10T23:59:59+00:00
Accession:  0001193805-24-001102
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunic hosts MS R&D Day, discusses vidofludimus calcium for relapsing and progressive MS
--------------------------------------------------------------------------------

- Immunic held a multiple sclerosis R&D Day on September 10, 2024.
- Presentation focused on vidofludimus calcium (IMU-838) for relapsing and progressive multiple sclerosis.
- No specific clinical or financial data from the presentation were disclosed in this 8-K.
- The presentation was furnished as Exhibit 99.1 but is not summarized in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380524001102/0001193805-24-001102-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380524001102/e663880_8k-immunic.htm
  HTML page:      https://secwatch.observer/filing/0001193805-24-001102

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer